Orphanet

Orphanet

Orphanet is an organisation and knowledge base dedicated to rare diseases as well as corresponding diagnosis, orphan drugs, clinical trials and expert networks. Orphanet was founded in France in 1997 by Inserm, the French National Institute of Health and Medical Research. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Orphanet, France, covering academic research published from 2004 to 2024. Read More.


Open Access Percentage

75%


Total
Publications

122


Total Open
Publications

91


Total
Citations

8K


Open Access
Percentage

75%


Total
Publications

122


Total Open
Publications

91


Total
Citations

8K

Wikipedia

Website

download

Breakdown

15% 54% 4% 27%

Publisher Open

15%

Both

54%

Other Platform Open

4%

Closed

27%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

58%OA Journal

OA Journal 58%

47

Hybrid 28%

23

No Guarantees 14%

11

Other Platform Open

Domain 88%

63

Institution 57%

41

Other Internet 14%

10

Public 7%

5

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
63
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
23
DANS - Data Archiving and Networked Services
Institution
15
Europe PMC
Domain
10
DOI
Other Internet
9
Universitat Pompeu Fabra - Repositori digital de la UPF
Institution
8
University of Siena - Use Siena air
Institution
7
University of Cambridge - Apollo
Institution
7
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
6
University of Ferrara - Institutional Research Information System University of Ferrara
Institution
4
1 / 5

Data updated 18 August 2025

Share

Share

Share